| Malignancies by Type | Year of Transplant | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | |
| Total # of Post-Tx Malignancies | 380 | 331 | 323 | 359 | 305 | 323 | 318 | 226 | 123 | 38 |
| Squamous/Basal Cell Carcinoma | 150 | 152 | 134 | 133 | 111 | 115 | 118 | 68 | 34 | 10 |
| Melanoma | 15 | 5 | 7 | 14 | 10 | 6 | 13 | 7 | 8 | - |
| Kaposi Sarcoma | 5 | 2 | 1 | 3 | - | 1 | - | - | 2 | - |
| Central Nervous System | 2 | 1 | 3 | 2 | 2 | 4 | 1 | 5 | 4 | - |
| Genito-Urinary (1) | 32 | 34 | 38 | 28 | 41 | 28 | 28 | 18 | 11 | 4 |
| Gastro-Intestinal (2) | 52 | 35 | 36 | 28 | 36 | 38 | 28 | 29 | 14 | 5 |
| Primary Hepatic Tumor | 14 | 16 | 8 | 21 | 16 | 18 | 29 | 11 | 8 | 6 |
| Metastatic Hepatic Tumor | 6 | 9 | 13 | 17 | 13 | 20 | 21 | 15 | 7 | 2 |
| Larynx/Bronchi/Lung | 54 | 39 | 44 | 58 | 33 | 54 | 41 | 41 | 16 | 5 |
| Breast/Thyroid | 19 | 10 | 15 | 15 | 13 | 9 | 11 | 10 | 2 | - |
| Leukemia | - | 2 | 1 | 2 | 5 | 6 | 2 | - | 3 | - |
| Sarcoma (3) | 1 | 1 | - | 3 | 3 | 2 | 2 | - | 1 | - |
| Other | 22 | 21 | 16 | 31 | 18 | 19 | 23 | 18 | 12 | 6 |
| Unknown | 8 | 4 | 7 | 4 | 4 | 3 | 1 | 4 | 1 | - |
| Squamous/Basal Cell Carcinoma | 39.5% | 45.9% | 41.5% | 37.0% | 36.4% | 35.6% | 37.1% | 30.1% | 27.6% | 26.3% |
| Melanoma | 3.9% | 1.5% | 2.2% | 3.9% | 3.3% | 1.9% | 4.1% | 3.1% | 6.5% | - |
| Kaposi Sarcoma | 1.3% | 0.6% | 0.3% | 0.8% | - | 0.3% | - | - | 1.6% | - |
| Central Nervous System | 0.5% | 0.3% | 0.9% | 0.6% | 0.7% | 1.2% | 0.3% | 2.2% | 3.3% | - |
| Genito-Urinary (1) | 8.4% | 10.3% | 11.8% | 7.8% | 13.4% | 8.7% | 8.8% | 8.0% | 8.9% | 10.5% |
| Gastro-Intestinal (2) | 13.7% | 10.6% | 11.1% | 7.8% | 11.8% | 11.8% | 8.8% | 12.8% | 11.4% | 13.2% |
| Primary Hepatic Tumor | 3.7% | 4.8% | 2.5% | 5.8% | 5.2% | 5.6% | 9.1% | 4.9% | 6.5% | 15.8% |
| Metastatic Hepatic Tumor | 1.6% | 2.7% | 4.0% | 4.7% | 4.3% | 6.2% | 6.6% | 6.6% | 5.7% | 5.3% |
| Larynx/Bronchi/Lung | 14.2% | 11.8% | 13.6% | 16.2% | 10.8% | 16.7% | 12.9% | 18.1% | 13.0% | 13.2% |
| Breast/Thyroid | 5.0% | 3.0% | 4.6% | 4.2% | 4.3% | 2.8% | 3.5% | 4.4% | 1.6% | - |
| Leukemia | - | 0.6% | 0.3% | 0.6% | 1.6% | 1.9% | 0.6% | - | 2.4% | - |
| Sarcoma (3) | 0.3% | 0.3% | - | 0.8% | 1.0% | 0.6% | 0.6% | - | 0.8% | - |
| Other | 5.8% | 6.3% | 5.0% | 8.6% | 5.9% | 5.9% | 7.2% | 8.0% | 9.8% | 15.8% |
| Unknown | 2.1% | 1.2% | 2.2% | 1.1% | 1.3% | 0.9% | 0.3% | 1.8% | 0.8% | - |
| Total # of Patients | 271 | 254 | 241 | 270 | 228 | 247 | 235 | 173 | 99 | 33 |